MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-06-0012008
Medpat Pharma Private Limited
Medpat Pharma Private Limited - service in Haridwar, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.02 Cr
▲ 17% YoY
Net profit · FY 2025
₹2.62 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹7.08 Lakh
EBITDA margin 2.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
22
Provident fund records
Directors on board
3
As per MCA filings
About Medpat Pharma Private Limited
Data last updated:
Medpat Pharma Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the service-based operations segment of the services sector. It was incorporated on 21 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U93090UR2018PTC009231. Its GSTIN is 05AAMCM2430P1Z7 (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Saajan Kumar Goswami and Narendra Mohan Malkani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Dr. Pooran Giri Near Karnataka Bank East Nath Nagar Arya Nagar Jwalapur, Haridwar, Uttarakhand, India – 249407.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.02 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹2.62 Lakh (net margin 0.9%) and EBITDA of ₹7.08 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
Medpat Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0012008). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U93090UR2018PTC009231
Registration Number 009231
Incorporation Date 21 November 2018
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-06-0012008
Recognitions & Rankings of Medpat Pharma
Contact details
Medpat Pharma Private Limited's registered office is in Haridwar, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Dr. Pooran Giri Near Karnataka Bank East Nath Nagar Arya Nagar Jwalapur, Haridwar, Uttarakhand, India – 249407
- IndustryService, Other Services
To see the full contact details of Medpat Pharma Private Limited, buy the company report.
Comprehensive company report
Medpat Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medpat Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medpat Pharma Private Limited, buy the company report.
Financials of Medpat Pharma Private Limited
FY 2025 filings availableMedpat Pharma Private Limited reported revenue of ₹3.02 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹3.02 Cr ▲ 17%
Net profit · FY 2025
₹2.62 Lakh margin 0.9%
EBITDA · FY 2025
₹7.08 Lakh margin 2.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 13%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 117%
3 years · compounded
▲ 62%
5 years · compounded
▲ 77%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 17% growth in the latest year. EBITDA rose 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medpat Pharma Private Limited, buy the company report.
Board of directors of Medpat Pharma Private Limited
Medpat Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saajan Kumar Goswami | Director | 21 Nov 2018 | 7 Years 11 Months | Current |
| Narendra Mohan Malkani | Director | 21 Nov 2018 | 7 Years 11 Months | Current |
| Raajan Kumar | Director | 21 Nov 2018 | 7 Years 11 Months | Current |
Peer comparison
Medpat Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| WTC Enterprises Private Limited | ₹3.02 Cr (FY 2024) | -6.0% | Mumbai, Maharashtra, India | |||
| Cloud 7 Pharma Private Limited | ₹3.02 Cr (FY 2025) | 99.0% | Chennai, Tamil Nadu, India | |||
| Noiaty Vincom Pvt.Ltd. | ₹3.02 Cr (FY 2021) | 158827.0% | Kolkata, West Bengal, India | |||
| Ved Gases Private Limited | ₹3.02 Cr (FY 2025) | -17.0% | Sitarganj, Uttarakhand, India | |||
| Jaxrane Remedies Private Limited | ₹3.02 Cr (FY 2025) | -29.0% | Jagadhri, Haryana, India | |||
| Medpat Pharma Private Limitedthis company | ₹3.02 Cr (FY 2025) | ₹2.62 Lakh | 0.9% | 17.0% | 22 | Haridwar, Uttarakhand, India |
| Bareilly Marketing Private Limited | ₹3.02 Cr (FY 2024) | -12.0% | Uttar Pradesh, India | |||
| Nutrizoe Nutriifoods Private Limited | ₹3.02 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| VP Kommodity Trade (I) Private Limited | ₹3.02 Cr (FY 2024) | -5.0% | Mumbai, Maharashtra, India | |||
| Agriloft Enterprises Private Limited | ₹3.02 Cr (FY 2024) | 21.0% | Delhi, India | |||
| Maaxmus Life Sciences Private Limited | ₹3.02 Cr (FY 2024) | 13.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Medpat Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medpat Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medpat Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medpat Pharma Private Limited has a workforce of 22 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
22
Active EPFO establishments
1
Employee growth
-4.35%
GST
Medpat Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAMCM2430P1Z7 | Uttarakhand | Active | 20 Jan 2019 |
To see the full GST registrations and return filing status of Medpat Pharma Private Limited, buy the company report.
Recent activity
Medpat Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Narendra Mohan Malkani was appointed as Director on 21 Nov 2018.
AGM
Medpat Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medpat Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Appointed
Narendra Mohan Malkani was appointed as Director.
Appointed
Raajan Kumar was appointed as Director.
Appointed
Saajan Kumar Goswami was appointed as Director.
Incorporation
21 Nov 2018
Medpat Pharma Private Limited was registered on 21 Nov 2018 with Roc Uttarakhand & aged 7 years 11 months as per MCA records.
Frequently asked questions
Medpat Pharma is an active private limited company based in Haridwar, Uttarakhand, India. The company works in other services, within the service industry. It was incorporated on 21 November 2018 (8+ years old) and is registered under CIN U93090UR2018PTC009231.
Medpat Pharma has 3 current directors:
- Saajan Kumar Goswami - Director
- Narendra Mohan Malkani - Director
- Raajan Kumar - Director
The latest financial statements of Medpat Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Medpat Pharma is 05AAMCM2430P1Z7, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Medpat Pharma is U93090UR2018PTC009231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medpat Pharma was incorporated on 21 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Medpat Pharma by revenue are WTC Enterprises Private Limited, Cloud 7 Pharma Private Limited, Noiaty Vincom Pvt.Ltd, Ved Gases Private Limited, Jaxrane Remedies Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Narendra Mohan Malkani was appointed as Director on 21 Nov 2018. Raajan Kumar was appointed as Director on 21 Nov 2018. Saajan Kumar Goswami was appointed as Director on 21 Nov 2018.
Yes, Medpat Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0012008).
The registered office of Medpat Pharma is at CO Dr. Pooran Giri Near Karnataka Bank East Nath Nagar Arya Nagar Jwalapur, Haridwar, Uttarakhand, India – 249407.
Medpat Pharma operates in the service industry, in the other services segment.